iShares Nasdaq Biotechnology (IBB) option IV at low end of range

iShares Nasdaq Biotechnology (NASDAQ: IBB) 30-day option implied volatility is at 14; compared to its 52-week range of 14 to 35 after President Biden unveils first 10 drugs subject to Medicare price negotiation.

You May Also Be Interested In

• Apple (AAPL) call put ratio 1.1 calls 1 put into hosting a special event
• TransUnion (TRU) call put ratio 1 call to 4.2 puts with a focus on January 47.50 puts as share price down 9.5%
• Alibaba (BABA) call put ratio 2.6 calls to 1 put with a focus on November and December calls